MENU
GHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GH Research (GHRS) Ownership - Who owns GH Research?
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Profile
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
830.57M
P/E Ratio
N/A
Total Cash
291.54M
Projected Growth
N/A
Total Debt
647K
Revenue
N/A
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash/Share
4.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GHRS
Capitalization
831M
P/E Ratio
N/A
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash
292M
Total Cash/Share
4.70
Total Debt
647K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
303M
P/B Ratio
2.79
Cash Flow
N/A
Earnings
-0.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.55M
Current Ratio
29.49
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-40.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.76
Shares Held By Institutions
484M
Shares Outstanding - Current
62M
Total Liabilities
10.2M
Total Volume MTD
N/A
Value
1
Gain YTD
94.714
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GHRS showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com